Skip Navigation

This Article
Right arrow Abstract
Right arrow FREE Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrowRequest Permissions
Right arrow Disclaimer

Introduction of a cyclophosphamide-based treatment strategy and the risk of ESRD in patients with idiopathic membranous nephropathy: A nationwide survey in the Netherlands
Nephrol. Dial. Transplant. Hofstra and Wetzels 23: 3534

Supplementary Data

Supplementary Data

Files in this Data Supplement:



This Article
Right arrow Abstract
Right arrow FREE Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrowRequest Permissions
Right arrow Disclaimer